- Dangers of Pharmacy Compounding: 1000-fold Overdose of Clonidine (CATAPRES) Used in a Child for Attention Deficit/Hyperactivity Disorder (ADHD) [hide all summaries]
(December 2001)
Physicians at Texas Tech University’s Health Sciences Center in Lubbock reported, in the August issue of the journal Pediatrics, the case of a five-year-old boy who received a massive overdose of the high blood pressure lowering drug clonidine (CATAPRES) that was being used to treat Attention Deficit/Hyperactivity Disorder (ADHD). Thankfully, he survived. - Submission to the Food and Drug Administration Docket on drugs that present difficulties for compounding (HRG Publication #1532) [hide all summaries]
This change in the law has given compounding pharmacists an end run around the FDA approval process and has opened the door for unethical pharmacists to copy commercially available FDA-approved drugs and to perpetrate the dangerous quackery that is now rampant within the practice of pharmacy compounding. - Comments in opposition to the Food and Drug Administration's Pharmacy Compounding Advisory Committee in opposition to the Pharmacy Compounding Provisions of the Food and Drug Administration Modernization Act (FDAMA) (HRG Publication #1529) [hide all summaries]
Public Citizen is opposed to the pharmacy compounding provisions of the Food and Drug Administration Modernization Act (FDAMA). These anti-scientific provisions of the law permit compounding pharmacists to conduct an "end run" around the FDA's drug approval process. - Quoted from Worst Pills.org
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Monday, July 14, 2014
Hello! Is Anyone Paying Attention? More History on What Harms Compounded Medications Have Caused
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment